Please Note: Gozonews.Com is now simply Gozo.News - Kindly update your bookmarks and links - Existing Gozonews.Com links should continue to function correctly

New dog vaccine against Sand-fly to be launched in Malta

Email item Email item Print item Print item

New dog vaccine against Sand-fly to be launched in MaltaThe Malta Veterinary Association has said that a new dog vaccine against Leishmaniosis, which is such a big problems for dogs across the Maltese islands, will shortly be available on the market for all its members.

The vaccine is at the moment available from a limited number of practices but has not yet been officially launched under the manufacturer’s guidance.

The Association warned that “misuse of the vaccine can be detrimental to the dogs’ health and create a national epidemic as leishmaniosis is in fact a zoonotic disease.”

The most important points to consider are:

the vaccine reduces the risk of the disease fourfold.

the dog to be vaccinated must be tested prior to vaccination with a reliable serologic test.

other repellent products currently used to prevent infection must still be applied on the dog.

Canine vaccine against Leishmania infantum adjuvanted

The MVA has made a document available that is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use. This document cannot replace a face-to-face discussion with a veterinarian.

If more information is needed about an animal’s medical condition or treatment, contact a veterinarian.

What is CaniLeish?

CaniLeish is a vaccine. It is available as a powder and solvent that is made up into suspension for injection. It contains Leishmania infantum excreted secreted proteins (ESP).

What is CaniLeish used for?

CaniLeish is used to vaccinate dogs from six months of age to reduce the risk of developing an active infection and clinical disease after contact with Leishmania infantum.

Leishmania infantum is a parasite that causes leishmaniosis. It is widespread in countries bordering the Mediterranean Sea. The parasite is transmitted from an infected dog to a non-infected dog by the bites of sand flies. Dogs that have been infected may show no signs of infection, but some do (fever, hair and weight loss, skin sores) and in the latter case the outcome of active infection can be fatal. Infected dogs play a central role in the accidental transmission of parasites to humans.

CaniLeish is to be used only in ‘leishmania-negative’ dogs. The detection of Leishmania infection using a rapid diagnostic test is recommended before vaccination.

The vaccine is given to dogs as three injections, three weeks apart, under the skin. The first injection can be given from six months of age, the second injection is given three weeks later and the third three weeks from the second one. Afterward a single ‘booster’ should be given every year to maintain the vaccine’s effect.

Veterinarians should assess the benefit-risk balance before vaccinating dogs in areas with little or no Leishmania infantum.

How does CaniLeish work?

CaniLeish is a vaccine that contains a number of proteins that are released from the Leishmania infantum parasite during its growth.

CaniLeish is a vaccine. Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.

When CaniLeish is given to dogs the immune system recognises the proteins as ‘foreign’ and make defences against it. In the future, if the animals are exposed to Leishmania infantum parasite, the immune system will be able to respond more quickly. This will help to protect against the disease.

CaniLeish contains an ‘adjuvant’ (a highly purified fraction of Quillaja saponaria) to enhance the immune response.

How has CaniLeish been studied?

The safety of the vaccine was studied in two main laboratory safety studies carried out in leishmania-free dogs (overdose and single and repeated administration) and one field trial. The vaccine was generally well tolerated as shown by the absence of major adverse reactions.

The efficacy of the vaccine was studied in one main field trial that lasted for two years involving vaccinated and control dogs submitted to natural exposure to infection in zones where there is a high risk of infection. A number of laboratory trials where dogs were submitted to experimental infection were also presented.

What benefit has CaniLeish shown during the studies?

The studies showed that the vaccine is safe for both leishmania-negative and leishmania-infected dogs. The benefit of the vaccination was assessed in zones with a high risk of infection where it has been shown in leishmania free dogs to decrease the risk of developing an active infection and a symptomatic disease after contact with the parasite. The number of dogs developing an active infection and a symptomatic disease was significantly reduced in the vaccinated group.

The efficacy of vaccination in dogs already infected was not investigated and therefore cannot be recommended. In dogs developing leishmaniosis (active infection or disease) despite vaccination, proceeding with vaccine injections showed no benefit.

The risk of vaccine-induced infection can be excluded since the vaccine does not contain parasites.

What is the risk associated with CaniLeish?

After injection, some dogs can have moderate and temporary local reactions, such as swelling, nodule (hardening), pain on palpation or erythema (reddening). These reactions resolve spontaneously within two days to two weeks. Other temporary signs commonly seen following vaccination can also occur such as hyperthermia (raised body temperature), apathy (lack of vitality) and digestive disorders lasting one to six days.

Allergic-type reactions are uncommon and if a dog shows signs of an allergic reaction, they should be given appropriate symptomatic treatment.

After vaccination transient antibodies against leishmania detected by immunofluorescence antibody test (IFAT) may appear but do not reflect an active infection.

What are the precautions for the person who gives the medicine or comes into contact with the animal? In case of accidental self-injection, the advice of a doctor should be sought immediately.

Why has CaniLeish been approved?

The CVMP concluded that the benefits of CaniLeish outweigh the risks for the active immunisation of leishmania-negative dogs from six months of age to reduce the risk to develop an active infection and clinical disease after contact with Leishmania infantum and recommended that CaniLeish be given a marketing authorisation. The benefit-risk balance may be found in the scientific discussion module of this EPAR.

  • Permalink: New dog vaccine against Sand-fly to be launched in Malta
  • You may also like...

    12 Responses

    1. betty berry says:

      This is great news, given the high numbers of Leishmaniasis positive dogs on the Maltese Islands. Prevention is always better than cure; however it should be borne in mind that an already infected dog can lead a long and healthy life, as long as it is given the daily recommended treatment.

    2. C.Corrado says:

      This is great news for all the dog lovers !!! The below article might help people how to further protect the dog after vaccinating him

    3. Jim Pilson says:

      Some re assurance needed please! We have a smallish mongrel dog, 10 kg approx and 8 years old. He had his first leishmania vaccine without any side affects, however, within a few hours of his second injection, he was in a great deal of pain and swollen all over his body, he could barely move and nearly collapsed every time he stood up, walking was difficult for him and a huge amount of persuasion was necessary for him to struggle to do a pee. Every time we touched him anywhere on his body, necessary because he couldn’t move very much, he screamed in pain and trembled with fear. He had a slight temperature and was obviously very miserable. We spoke to our vet and he said not to worry as it is normal for some dogs to have a reaction, we took him to the clinic the next day, even though he was a little better and the vet gave him an injection and pills for the next two days. He informed us that his dog suffered reactions too, but not to worry. He told us that the third injection will give an even more severe reaction and he will give us the necessary pills etc to try and prevent some of the adverse reaction. We have an excellent, caring vet, but we are English and he is Spanish and therefore getting all the information is obviously difficult. The third injection is due on the 11th January and we are very worried indeed. Also, we know that there is the need for a yearly injection, or is it another course of three injections and what are the risks to adverse reactions in the future and are they cumulative? We would really appreciate some information, good or bad. Thank you from two very worried and fearful owners.

      • chris green says:

        @Jim Pilson. I cannot believe that you might consider putting your dog through potentially more severe pain and discomfort. Please do not inflict this treatment. Change your vet to someone more sympathetic ith the animal.

    4. chris green says:

      I cannot believe that you might consider putting your poor dog through potentially more severe pain and discomfort. Please do not inflict this treatment. Change your vet to someone more sympathetic with the animal.

      • Chloe says:

        What do you mean Mr Green????

      • chris green says:

        @Chloe. If you wish to challenge my letter then please do so with a structured argument to which I can respond.

      • Chloe says:

        I beg your pardon but you commented on an article regarding the vaccination against leishmania and your comment was ‘I cannot believe that you might consider putting your poor dog through potentially more severe pain and discomfort. Please do not inflict this treatment. Change your vet to someone more sympathetic with the animal. I politely asked what is it that you mean by it.

      • chris green says:

        My original comment re-submitted @ Jim Pilson. Happy Chloe?

      • Chloe says:

        I think you need to chill or try some herbal remedies Sir

      • Chloe says:

        I asked it you out of concern as i have a dog too and was considering giving him the vaccine. I thought you were referring to the article. No need to be so hostile

    5. Cynthia Bellia says:

      Just given my puppy first.vaccination and hoping she will not be in a lot of pain

    Leave a Reply

    Your email address will not be published. Required fields are marked *